secwatch.observer — SEC 8-K summary
======================================

Issuer:     RELMADA THERAPEUTICS, INC. (RLMD)
CIK:        0001553643
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001213900-25-088360
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relmada Therapeutics furnishes updated corporate presentation; details unavailable
--------------------------------------------------------------------------------

- 8-K filed September 17, 2025 includes updated corporate presentation as Exhibit 99.1.
- Presentation titled 'Unlocking Life Changing Therapies' but specific content not provided in filing text.
- No financial or clinical data disclosed in the available filing excerpt; review full presentation for updates.
- Filing under Regulation FD; information is furnished, not filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553643/000121390025088360/0001213900-25-088360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553643/000121390025088360/ea0257659-8k_relmada.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-088360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer